Sutro Biopharma, Inc. (STRO) by event type

STRO moves most on analyst downgrades — a median of -9.98% at 30 minutes across 17 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the STRO overview →

By event type

How STRO reacts across 4 measured event types.

EventEventsMedian 30-min% positiveMedian to close
Analyst upgrades
2,682 of 2,717
22-1.69%41%+1.41%
Analyst downgrades
2,597 of 2,603
17-9.98%18%-18.99%
Coverage initiations
1,622 of 2,283
20-0.18%40%-0.49%
Rating reiterations
3,077 of 3,522
71-0.27%45%+0.54%

Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.

That’s how STRO usually reacts — get an email when it moves on news →
Keep exploring

Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · STRO overview →

Other Healthcare names, measured the same way

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.